SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending following news of a strategic manufacturing partnership to scale production of its Intelligent Fingerprinting Drug Screening Reader, ahead of its anticipated U.S. market entry and promising significant operational benefits. The community is actively debating its low float and short squeeze potential, with many discussing whether recent price action is a "stop raid" for further upside or a sign of an impending offering.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is a top trending stock, with intense community discussion centered on its extremely low float and strong potential for a short squeeze. Many traders are actively accumulating shares, comparing it to recent parabolic runners and speculating on a multi-day breakout, especially as the company explores strategic alternatives.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to its volatile price action as a low-float SPAC, prompting intense community discussion around its potential for a short squeeze or significant gains. Traders are closely watching its 'tiny float' and high insider ownership, drawing parallels to other recent 'shell company rippers' amidst sharp price swings and trading halts. This speculative interest sees many buying dips and holding, anticipating further explosive moves.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following its recent FDA approval of NEREUS, the first new motion sickness treatment in over four decades. Community discussion highlights the drug's significant potential beyond its initial indication, particularly its promising application for GLP-1 induced nausea, which many anticipate could unlock a massive market. This approval, coupled with upcoming pipeline catalysts, fuels widespread speculation about a potential buyout from a larger pharmaceutical entity.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is currently trending amidst significant anticipation for a pending Department of Energy announcement regarding awards for surplus plutonium, which could provide the company with crucial, potentially low-cost fuel. The community is actively debating the stock's valuation and the implications of potential zero-cost fuel, with bulls noting signs of institutional accumulation and unusual options activity while bears highlight zero revenue and recent insider selling. This potential award is seen as a game-changer for the small modular reactor company, aligning with the broader demand for carbon-free energy in the AI revolution.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following recent regulatory updates, including the FDA's priority review for its AXS-05 Alzheimer's disease agitation treatment and progress towards an NDA submission for AXS-12 in narcolepsy. The community is highly optimistic about these developments and continued strong sales of Auvelity, viewing the company as a future leader in CNS therapeutics with significant pipeline potential. This confluence of catalysts has fueled substantial investor enthusiasm, driving the stock to new highs.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena > Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

COCK CRYPTO is a trending topic, driven by its unique real-world utility through the CockyWings LLC food truck business, which generates revenue for token buybacks. Community discussions highlight its newly launched Memes Hub DAPP and liquid staking platform, offering passive gains, solidifying its position as a distinctive asset within the Cardano meme coin space.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens is trending amid widespread debate over its value proposition, with strong bearish sentiment calling it "garbage" and a "scam" conflicting with bullish expectations for institutional adoption. Despite community skepticism and calls for further declines, renewed focus on its ISO 20022 compliance and ongoing network developments are fueling optimism for a potential rebound.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics experienced a sharp sell-off after the FDA issued a Complete Response Letter for its relacorilant drug in Cushing's syndrome, seeking additional efficacy evidence despite trial success. This dramatic drop has split the community, with many investors calling it an overreaction given the company's profitable Korlym revenue and extensive pipeline, while others remain wary of further downside amid the regulatory uncertainty.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is currently trending amid heavy end-of-year profit-taking and tax loss harvesting, leading to widespread discussion about a 'failed Santa rally' and an 'extremely bad close'. Community sentiment is sharply divided, with bulls hoping for a strong rebound in the new year, potentially driven by AI and computing power, while bears anticipate continued volatility and further declines in the upcoming trading period. Many are debating if the current dip is a temporary calendar effect or a precursor to a larger market correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company plans to use its uranium enrichment expansion to support a $2.3 billion backlog of uranium contracts from domestic and international customers.</li><li>The company recently raised $1.2 billion in convertible notes and launched a $1 billion at-the-market offering to fund expansion.</li><li>Evercore reiterated an ‘Outperform’ rating on the stock and maintained a $390 price target.</li></ul>Shares of Centrus Energy Corp. (LEU) jumped 15% on Friday after the company said it has begun manufacturing centrifuges domestically, a step Wall Street views as a move to capitalize on its “first-mover advantage.”The company said the manufacturing activity will support commercial production of low-enriched uranium&nbsp;(LEU)&nbsp;at its Piketon facility in Ohio. The company plans to use its uranium enrichment expansion to support a $2.3 billion backlog of LEU contracts from domestic and international customers, and eventually scale production of high-assay LEU (HALEU).<h2 class="st-heading-2">Funding Details</h2>Centrus’ expansion goals are backed by multiple funding channels, including Department of Energy (DOE) task orders that could total around $900 million each for LEU and HALEU production. The company has also raised $1.2 billion in convertible notes and recently launched a $1 billion at-the-market offering.“We make this announcement after carefully evaluating the business’ internal and external progress as well as its future prospects and many competitive advantages. These include the significant progress in building our supply chain; the advancement across the many available avenues to acquire low-cost of capital to support our build, including imminent DOE funding announcements; and, evaluating the progress in our internal manufacturing capabilities,” said Amir Vexler, Centrus Energy CEO and President.<h2 class="st-heading-2">Evercore Reiterates ‘Outperform’ Rating</h2>Evercore reiterated an ‘Outperform’ rating on the stock and maintained a $390 price target, according to The Fly. This represents a 50% upside from its current price of around $260.The firm said Centrus Energy’s start of domestic centrifuge manufacturing is a clear signal that the company is moving to capitalize on its “first-mover advantage” in U.S. uranium enrichment.Evercore called the decision to begin manufacturing ahead of a formal DOE allocation a “meaningful positive indicator” for the stock, reflecting confidence in Centrus’ ability to fund the build-out through multiple financing paths.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the strong intraday gains, retail sentiment on Stocktwits remained ‘neutral’ over the past 24 hours, even as chatter was ‘high’.Users were generally bullish, with one watcher expecting the stock to climb to $270.<stembedurl>https://stocktwits.com/JoeAlerts/message/639694360</stembedurl>Another user expects the stock to hit $300 before the year ends.<stembedurl>https://stocktwits.com/JoeAlerts/message/639691306</stembedurl>The stock has gained more than 280% in the past year.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-ccl-stock-surge-today/cLeiCeTREso">Why Did CCL Stock Surge 9% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Centrus Energy logo is seen displayed on a smartphone screen.

Why Is Centrus Energy Corp Stock Rising Today?

Centrus Energy began manufacturing centrifuges domestically to support commercial production of low-enriched uranium at its Piketon facility in Ohio.

Equity

<ul class="summary-bullets"><li>UAMY stock rebounded from its 200-DMA in July this year; the last time it fell below the line was in July 2024.</li><li>The company’s Q3 net loss widened significantly to $4.8 million, and it narrowed its FY2025 revenue guidance.</li><li>In October, Australia’s Larvotto Resources had rejected a buyout offer from UAMY.</li></ul>United States Antimony Corp. (UAMY) stock fell 3% on Tuesday and is trading close to its 200-day moving average (200-DMA) for the first time since the beginning of July.&nbsp;<figure class="image"><img style="aspect-ratio:1306/937;" src="https://news.stocktwits-cdn.com/UAMY_png_971f6b465d.webp" alt="UAMY.png" width="1306" height="937"><figcaption>UAMY 200-DMA | Source: TradingView</figcaption></figure>The last time <a href="https://stocktwits.com/symbol/UAMY">UAMY</a> fell below the 200-DMA line was in July 2024. The stock has been on a steady decline after it reached a high of $19.7 in October, falling around 75%.<h2 class="st-heading-2">Q3 Results Snapshot</h2>In November, UAMY reported revenues of $8.7 million for the third quarter of 2025, a 238% increase from $2.6% million in the same period of 2024. Operating expenses surged to $6.93 million.However, net loss widened significantly to $4.8 million, compared with a loss of $729,384 in the prior-year period. The company also narrowed its full-year 2025 revenue guidance to $40-$43 million and reaffirmed its 2026 target of $125 million.<h2 class="st-heading-2">Key Developments In 2025</h2>In October, Australia’s Larvotto Resources rejected a buyout offer from UAMY, citing concerns that the proposed deal undervalued the company. UAMY had offered A$1.40 ($0.9) per share to acquire the remaining Larvotto shares it did not already own, having disclosed a 10% stake in the Australian miner before the offer.UAMY was pursuing the deal to expand its antimony production amid rising global demand, particularly given China’s export restrictions.In September, the American miner had secured a five-year, $245 million contract with the U.S. Defense Logistics Agency to supply antimony metal ingots for the defense stockpile.<h2 class="st-heading-2">Korea Zinc’s U.S. Investment</h2>UAMY stock tanked 11% on Monday after Korea Zinc announced plans to invest $7.4 billion to build a new smelter in the U.S to produce key metals and strategic minerals. The company said the U.S. government requested the project to help address rising supply-chain risks and growing domestic demand for non-ferrous metals.The facility will produce zinc, lead, and copper, as well as gold, silver, and strategic minerals, including antimony, germanium, and gallium.Construction is expected to begin in 2027, with commercial operations ramping up through 2029.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for UAMY on Stocktwits has remained in the ‘bearish’ territory for the past 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:919/99;" src="https://news.stocktwits-cdn.com/UAMY_retail_png_a785fb0116.webp" alt="UAMY retail.png" width="919" height="99"><figcaption>UAMY's Sentiment Meter and Message Volumes at 12:35 p.m. ET on Dec. 16, 2025 | Source: Stocktwits</figcaption></figure>One user explained why Korea Zinc’s investment will not deter UAMY’s operations.<stembedurl>https://stocktwits.com/GreyMarketRiseDestroySEC/message/639305586</stembedurl>Another user remains bullish on the stock, citing upcoming ‘catalysts’.<stembedurl>https://stocktwits.com/Lamadorian/message/639308855</stembedurl>The stock has a target price of $9.67, according to Koyfin data. Year-to-date, UAMY has gained 173%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/this-stock-crashed-35-just-days-after-posting-an-18-000-revenue-jump-what-triggered-the-sell-off/cLeJLTBREp5">This Stock Crashed 35% Just Days After Posting An 18,000% Revenue Jump –&nbsp; What Triggered The Sell-Off?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the United States Antimony (US Antimony) logo is seen displayed on a smartphone screen

UAMY Tumbles 75% In Two Months, Approaches 200-DMA For First Time Since July – But Retail Smells Opportunity

UAMY stock tanked 11% on Monday after Korea Zinc announced plans to invest $7.4 billion to build a new smelter in the U.S to produce strategic minerals.

5 ETF Areas That Held Steady In Friday's Bloodbath  

On Oct 10, 2025, Wall Street saw about $2 trillion in market value wiped out. However, ETFs like SIVR, TAIL, URA, PZA, and VNM held steady. Find out why.

Shares of Oklo, Inc. (OKLO), a nuclear fission plant company, jumped nearly 29% on Friday, and the buoyancy will likely linger as they rose in overnight trading.<a href="https://stocktwits.com/symbol/OKLO">Oklo stock</a> is up a whopping 537% year-to-date, riding on the market opportunity provided by the increased power needs of&nbsp;AI data centers, especially for clean and reliable power.The stock broke out of a consolidation phase in early September and has gone parabolic after the company announced plans to build and operate a fuel recycling facility in Tennessee as the first phase of an advanced fuel center with an investment outlay of $1.68 billion.&nbsp;<img src="https://news.stocktwits-cdn.com/Oklo_YTD_stock_png_0b8ec13c16.webp" alt="Oklo YTD stock.png">Chart courtesy of KoyfinIn a note released late Sunday, Wedbush analyst Daniel Ives raised the price target for Oklo stock to $150 from $80, a whopping 90% hike, citing incremental confidence in the company’s nuclear growth strategy as the artificial intelligence (AI) revolution hits its next stride of growth. Ives has an ‘Outperform’ rating for the company’s stock. Oklo has a 2.5% weighting in the&nbsp;<a href="https://stocktwits.com/symbol/IVES">Dan Ives Wedbush AI Revolution ETF (IVES)</a> that was launched in June.&nbsp;“Our time spent in the Beltway last week with meetings on the Hill gave us incremental confidence that the push for nuclear energy in the US is now underway and positions OKLO very well for this wave of spending/growth/regulatory approval,” Ives said in the note.The analyst believes that Oklo remained one of the primary beneficiaries of the significantly increased US government support for nuclear energy, with the company being announced as an initial selection for two projects and one project for Atomic Alchemy in the Trump administration’s new Nuclear Reactor Pilot Program.He also sees Oklo benefiting from the major U.S. companies increasing investments into building data centers within the U.K., including Google, OpenAI, and CoreWeave. According to Ives, the U.K.’s decision to slash the licensing timeline to two years represents a massive acceleration for companies deploying small modular reactors (SMRs), including Oklo.Oklo stock was among the top five trending equity tickers on Stockwits late Sunday. The seven-day message volume change leading up to late Sunday was about 750%. Retail sentiment toward the stock stayed ‘extremely bullish (76/100), with the buoyancy accompanied by ‘extremely high’ message volume.<figure class="image"><img style="aspect-ratio:625/55;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_22_at_12_48_51_AM_png_5f5418219c.webp" alt="Screenshot 2025-09-22 at 12.48.51 AM.png" width="625" height="55"><figcaption>OKLO sentiment and message volume as of 12:45 a.m., Sept. 22 | source: Stocktwits</figcaption></figure>A bullish user has set a lofty target of $500 for the stock before the end of the year.<stembedurl>https://stocktwits.com/Joooopy9/message/629464944</stembedurl>Another watcher said everyone is bought into the AI-powered narrative that has been communicated clearly.<stembedurl>https://stocktwits.com/RideWitMe/message/629461107</stembedurl>That said, Wall Street isn’t equally enthusiastic. According to Koyfin, the average analyst’s price target is $73.75, implying over 45% downside from Friday’s closing price.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/snap-stock-s-retail-traders-on-high-alert-for-meme-rally/chDQaTDR3c3">Snap Stock’s Retail Traders On High Alert For Meme Rally As Buyout Speculation Resurfaces</a>

In this photo illustration,an OKLO logo is seen displayed on a smartphone and in the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)

Oklo Stock Set To Pop Again? Wall Street Tech Bull Hikes Price Target By 90% On Trump's Nuclear Thrust As Retail Traders Pile In

The analyst believes that Oklo remained one of the primary beneficiaries of the significantly increased US government support for nuclear energy.

Nuclear ETFs Soar YTD Under Trump Regime, Top 2024 Performance 

Nuclear ETFs like NLR, URA and URAN surge in 2025 as Trump's policy push, rising uranium prices and SMR deployment fuel solid gains. 

ETFs to Play the Potential $10 Trillion Nuclear Surge

Nuclear power is surging as AI-driven data centers fuel demand, with ETFs riding momentum and SMRs reshaping the sector's future.

The Zacks Analyst Blog Highlights NLR, NUKZ, URA and URAN

Nuclear power is back in the spotlight, with ETFs like NLR, NUKZ, URA, and URAN surging 40-88% in the past year as global demand for clean, reliable energy grows.

Nuclear ETFs Up At Least 40% in the Past Year: More Gains in Store?

Demand from tech giants is boosting interest in nuclear energy, but costs remain a hurdle. ETFs like NLR, URA, URAN and NUKZ have surged 40-80% in a year.

Uranium Demand to Jump 28%: ETFs in Focus

Uranium demand could surge nearly 30% in five years, fueled by AI-driven energy needs and nuclear power's clean energy edge.

Shares of Oklo (OKLO) hit a new record on Tuesday, reaching a high of $85.20, after a report that the U.S. is planning to set up a nuclear reactor on the moon.&nbsp;&nbsp;<a href="https://stocktwits.com/symbol/OKLO">Oklo’s stock</a> was up more than 7% at the time of writing, having pared some gains to trade at $81.70.&nbsp;On Stocktwits, retail sentiment around the stock moved higher over the past day, but remained in ‘bearish’ territory.&nbsp;The jump comes after Politico&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.politico.com/news/2025/08/04/nasa-china-space-station-duffy-directives-00492172">reported</a> late Monday that Transportation Secretary and interim NASA head Sean Duffy plans to unveil expedited plans for a nuclear reactor on the moon by the end of the week. According to documents reviewed by Politico, the White House is ordering the agency to solicit industry proposals for a 100-kilowatt (KW) nuclear reactor to launch by 2030.President Donald Trump named Duffy as interim administrator of NASA in July after withdrawing the nomination of billionaire Jared Isaacman while he was caught up in an online feud with the nominee’s ally, Elon Musk.The report noted that NASA had previously funded research for setting up a 40 KW reactor on the moon, with plans to have a reactor ready for launch by the early 2030s. The first country to have a reactor could “declare a keep-out zone which would significantly inhibit the United States,” the directive stated, according to the report. The directive also orders NASA to assign a leader for the effort and to get industry input within 60 days of being issued.&nbsp;The report said NASA would be looking for companies that can launch a nuclear reactor by 2030 to counter China’s timeline, which intends to land its first astronaut on the moon that same year.&nbsp;Oklo’s stock has gained more than 50% this month and over 200% in 2025. In the past 12 months, the shares have rocketed more than 1,000% in value.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-warns-eu-of-35-tariff-confirms-india-hike-within-24-hours/chrLqunRd2a">Trump Warns EU Of 35% Tariff, Confirms India Hike Within 24 Hours</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Oklo Stock Jumps To Record High On Reported Trump-Backed Push For Nuclear Reactor On The Moon

Politico reported late Monday that Transportation Secretary and interim NASA head Sean Duffy plans to unveil expedited plans for a nuclear reactor on the moon by the end of the week. 

URA
Global X Uranium ETF

Feed

News

Sentiment

Fundamentals

Info

Latest URA News

URAGlobal X Uranium ETF